Public Health England turns its drug production facility into a limited company

BMJ 2015; 351 doi: (Published 10 July 2015) Cite this as: BMJ 2015;351:h3780
  1. Nigel Hawkes
  1. 1London

Public Health England has transferred its drug development and production department to a new standalone company, Porton Biopharma, which will remain state owned. Its managing director, Roger Hinton, said that the change would enable the company to shape its own future, pursue more opportunities, and respond more rapidly to changes in global …

View Full Text

Log in

Log in through your institution


* For online subscription